KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Intangibles: 2009-2024

Historic Intangibles for Pacira BioSciences (PCRX) over the last 13 years, with Dec 2024 value amounting to $426.0 million.

  • Pacira BioSciences' Intangibles fell 13.15% to $382.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $382.4 million, marking a year-over-year decrease of 13.15%. This contributed to the annual value of $426.0 million for FY2024, which is 11.85% down from last year.
  • As of FY2024, Pacira BioSciences' Intangibles stood at $426.0 million, which was down 11.85% from $483.3 million recorded in FY2023.
  • Pacira BioSciences' Intangibles' 5-year high stood at $624.0 million during FY2021, with a 5-year trough of $96.5 million in FY2020.
  • Its 3-year average for Intangibles is $483.3 million, with a median of $483.3 million in 2023.
  • In the last 5 years, Pacira BioSciences' Intangibles soared by 546.46% in 2021 and then fell by 13.37% in 2022.
  • Pacira BioSciences' Intangibles (Yearly) stood at $96.5 million in 2020, then soared by 546.46% to $624.0 million in 2021, then dropped by 13.37% to $540.5 million in 2022, then declined by 10.60% to $483.3 million in 2023, then dropped by 11.85% to $426.0 million in 2024.